Skip to content
Evigrade
MajorMacrolides×Class III antiarrhythmic, selective IKr blocker

Updated · Methodology

Mechanism

Dofetilide is a class III antiarrhythmic. It blocks the rapid component of the delayed rectifier potassium current (IKr), and QT prolongation depends directly on its plasma concentration (dofetilide label, US Food and Drug Administration, FDA). QT prolongation with a risk of torsade de pointes has been seen with macrolides, including azithromycin (azithromycin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; azithromycin FDA label), so the effects of the two drugs on QT may add up. Azithromycin is a weak inhibitor of cytochrome P450 enzymes, although inhibition of the CYP3A4 enzyme cannot be fully excluded. It also inhibits the transporter P-glycoprotein (P-gp) (AEMPS). CYP3A4 metabolises a small part of dofetilide, and the US dofetilide label lists macrolides among the CYP3A4 inhibitors that can increase dofetilide levels. But the kidneys remain the main route of dofetilide elimination. The documents do not state how much azithromycin changes dofetilide levels (dofetilide FDA label).

Symptoms

QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG). The Medication Guide of the US dofetilide label lists the warning signs of a dangerous arrhythmia: feeling faint, dizziness and a fast heartbeat. It warns that torsade de pointes can lead to death (dofetilide label, US Food and Drug Administration, FDA). In people with supraventricular arrhythmias who took dofetilide, torsade de pointes occurred in 0.8%, mostly within the first three days of treatment. Low potassium or magnesium increases the risk (FDA). Torsade de pointes has been reported with azithromycin, and the QT prolongation it causes can be fatal (azithromycin FDA label). According to the Spanish summary of product characteristics, taking other QT-prolonging drugs may increase the risk of ventricular arrhythmias, including torsade de pointes, that lead to cardiac arrest (azithromycin SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS).

Management

Avoid the combination. The US dofetilide label does not recommend dofetilide with other drugs that prolong the QT interval and names certain oral macrolides among the examples (dofetilide label, US Food and Drug Administration, FDA). According to its own documents, azithromycin prolongs the QT interval (azithromycin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; azithromycin FDA label). The azithromycin documents themselves are less strict: the Spanish SmPC advises caution in patients taking QT-prolonging drugs and names dofetilide (AEMPS). In patients taking class IA or class III antiarrhythmics, including dofetilide, the US label asks prescribers to weigh the risk of QT prolongation, which can be fatal, against the benefits of azithromycin (FDA). Neither the azithromycin documents nor the dofetilide label contraindicate the combination. Dofetilide is not in the Spanish medicines register CIMA. If dofetilide is stopped so that a potentially interacting drug can be given, wait at least two days before starting that drug. When restarting dofetilide, keep the patient for at least three days in a facility that can calculate creatinine clearance, provide continuous electrocardiogram (ECG) monitoring and perform cardiac resuscitation (FDA). After a single 500 mg dose, the terminal half-life of azithromycin is about 68 hours (AEMPS). No document states how long to wait after stopping azithromycin before starting dofetilide. Dofetilide is contraindicated if the QT or heart-rate-corrected QT interval (QTc) is above 440 ms (500 ms with ventricular conduction abnormalities). Stop dofetilide if the QTc exceeds 500 ms (550 ms with such abnormalities). Keep potassium in the normal range before and during treatment (FDA). Use azithromycin with caution in people with low potassium or magnesium, or with clinically relevant bradycardia (AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Azithromycin

Other interactions with Dofetilide